https://www.globenewswire.com/de/news-release/2025/10/15/3166805/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-64Cu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html
Curium Group, PeptiDream and PDRadiopharma Enroll First
curiumgroupenrollfirst
https://www.globenewswire.com/de/news-release/2026/02/04/3231755/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-Lu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html
Curium Group, PeptiDream and PDRadiopharma Enroll First
A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer...
curiumgroupenrollfirst